The Global Biosimilars of Rituximab Market Size was estimated at USD 1956.08 million in 2023 and is projected to reach USD 3191.29 million by 2029, exhibiting a CAGR of 8.50% during the forecast period.
Report Overview:
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells.
This report provides a deep insight into the global Biosimilars of Rituximab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biosimilars of Rituximab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biosimilars of Rituximab market in any manner.
Global Biosimilars of Rituximab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Amgen
- AryoGen Pharmed
- Biocad
- Cadila Pharmaceuticals
- Celltrion
- Dr Reddys Laboratories
- Teva
- Hetero Group
- Innovent Biologics
- Intas Biopharmaceuticals
- Viatris
- Probiomed
- TRPharma
- Zenotech Laboratories
Market Segmentation (by Type)
Market Segmentation (by Application)
- Hospital Pharmacy
- Retail Pharmacy
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biosimilars of Rituximab Market
- Overview of the regional outlook of the Biosimilars of Rituximab Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biosimilars of Rituximab Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biosimilars of Rituximab
1.2 Key Market Segments
1.2.1 Biosimilars of Rituximab Segment by Type
1.2.2 Biosimilars of Rituximab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biosimilars of Rituximab Market Overview
2.1 Global Market Overview
2.1.1 Global Biosimilars of Rituximab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biosimilars of Rituximab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biosimilars of Rituximab Market Competitive Landscape
3.1 Global Biosimilars of Rituximab Sales by Manufacturers (2019-2024)
3.2 Global Biosimilars of Rituximab Revenue Market Share by Manufacturers (2019-2024)
3.3 Biosimilars of Rituximab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biosimilars of Rituximab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biosimilars of Rituximab Sales Sites, Area Served, Product Type
3.6 Biosimilars of Rituximab Market Competitive Situation and Trends
3.6.1 Biosimilars of Rituximab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biosimilars of Rituximab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biosimilars of Rituximab Industry Chain Analysis
4.1 Biosimilars of Rituximab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biosimilars of Rituximab Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biosimilars of Rituximab Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biosimilars of Rituximab Sales Market Share by Type (2019-2024)
6.3 Global Biosimilars of Rituximab Market Size Market Share by Type (2019-2024)
6.4 Global Biosimilars of Rituximab Price by Type (2019-2024)
7 Biosimilars of Rituximab Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biosimilars of Rituximab Market Sales by Application (2019-2024)
7.3 Global Biosimilars of Rituximab Market Size (M USD) by Application (2019-2024)
7.4 Global Biosimilars of Rituximab Sales Growth Rate by Application (2019-2024)
8 Biosimilars of Rituximab Market Segmentation by Region
8.1 Global Biosimilars of Rituximab Sales by Region
8.1.1 Global Biosimilars of Rituximab Sales by Region
8.1.2 Global Biosimilars of Rituximab Sales Market Share by Region
8.2 North America
8.2.1 North America Biosimilars of Rituximab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biosimilars of Rituximab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biosimilars of Rituximab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biosimilars of Rituximab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biosimilars of Rituximab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amgen
9.1.1 Amgen Biosimilars of Rituximab Basic Information
9.1.2 Amgen Biosimilars of Rituximab Product Overview
9.1.3 Amgen Biosimilars of Rituximab Product Market Performance
9.1.4 Amgen Business Overview
9.1.5 Amgen Biosimilars of Rituximab SWOT Analysis
9.1.6 Amgen Recent Developments
9.2 AryoGen Pharmed
9.2.1 AryoGen Pharmed Biosimilars of Rituximab Basic Information
9.2.2 AryoGen Pharmed Biosimilars of Rituximab Product Overview
9.2.3 AryoGen Pharmed Biosimilars of Rituximab Product Market Performance
9.2.4 AryoGen Pharmed Business Overview
9.2.5 AryoGen Pharmed Biosimilars of Rituximab SWOT Analysis
9.2.6 AryoGen Pharmed Recent Developments
9.3 Biocad
9.3.1 Biocad Biosimilars of Rituximab Basic Information
9.3.2 Biocad Biosimilars of Rituximab Product Overview
9.3.3 Biocad Biosimilars of Rituximab Product Market Performance
9.3.4 Biocad Biosimilars of Rituximab SWOT Analysis
9.3.5 Biocad Business Overview
9.3.6 Biocad Recent Developments
9.4 Cadila Pharmaceuticals
9.4.1 Cadila Pharmaceuticals Biosimilars of Rituximab Basic Information
9.4.2 Cadila Pharmaceuticals Biosimilars of Rituximab Product Overview
9.4.3 Cadila Pharmaceuticals Biosimilars of Rituximab Product Market Performance
9.4.4 Cadila Pharmaceuticals Business Overview
9.4.5 Cadila Pharmaceuticals Recent Developments
9.5 Celltrion
9.5.1 Celltrion Biosimilars of Rituximab Basic Information
9.5.2 Celltrion Biosimilars of Rituximab Product Overview
9.5.3 Celltrion Biosimilars of Rituximab Product Market Performance
9.5.4 Celltrion Business Overview
9.5.5 Celltrion Recent Developments
9.6 Dr Reddy?s Laboratories
9.6.1 Dr Reddy?s Laboratories Biosimilars of Rituximab Basic Information
9.6.2 Dr Reddy?s Laboratories Biosimilars of Rituximab Product Overview
9.6.3 Dr Reddy?s Laboratories Biosimilars of Rituximab Product Market Performance
9.6.4 Dr Reddy?s Laboratories Business Overview
9.6.5 Dr Reddy?s Laboratories Recent Developments
9.7 Teva
9.7.1 Teva Biosimilars of Rituximab Basic Information
9.7.2 Teva Biosimilars of Rituximab Product Overview
9.7.3 Teva Biosimilars of Rituximab Product Market Performance
9.7.4 Teva Business Overview
9.7.5 Teva Recent Developments
9.8 Hetero Group
9.8.1 Hetero Group Biosimilars of Rituximab Basic Information
9.8.2 Hetero Group Biosimilars of Rituximab Product Overview
9.8.3 Hetero Group Biosimilars of Rituximab Product Market Performance
9.8.4 Hetero Group Business Overview
9.8.5 Hetero Group Recent Developments
9.9 Innovent Biologics
9.9.1 Innovent Biologics Biosimilars of Rituximab Basic Information
9.9.2 Innovent Biologics Biosimilars of Rituximab Product Overview
9.9.3 Innovent Biologics Biosimilars of Rituximab Product Market Performance
9.9.4 Innovent Biologics Business Overview
9.9.5 Innovent Biologics Recent Developments
9.10 Intas Biopharmaceuticals
9.10.1 Intas Biopharmaceuticals Biosimilars of Rituximab Basic Information
9.10.2 Intas Biopharmaceuticals Biosimilars of Rituximab Product Overview
9.10.3 Intas Biopharmaceuticals Biosimilars of Rituximab Product Market Performance
9.10.4 Intas Biopharmaceuticals Business Overview
9.10.5 Intas Biopharmaceuticals Recent Developments
9.11 Viatris
9.11.1 Viatris Biosimilars of Rituximab Basic Information
9.11.2 Viatris Biosimilars of Rituximab Product Overview
9.11.3 Viatris Biosimilars of Rituximab Product Market Performance
9.11.4 Viatris Business Overview
9.11.5 Viatris Recent Developments
9.12 Probiomed
9.12.1 Probiomed Biosimilars of Rituximab Basic Information
9.12.2 Probiomed Biosimilars of Rituximab Product Overview
9.12.3 Probiomed Biosimilars of Rituximab Product Market Performance
9.12.4 Probiomed Business Overview
9.12.5 Probiomed Recent Developments
9.13 TRPharma
9.13.1 TRPharma Biosimilars of Rituximab Basic Information
9.13.2 TRPharma Biosimilars of Rituximab Product Overview
9.13.3 TRPharma Biosimilars of Rituximab Product Market Performance
9.13.4 TRPharma Business Overview
9.13.5 TRPharma Recent Developments
9.14 Zenotech Laboratories
9.14.1 Zenotech Laboratories Biosimilars of Rituximab Basic Information
9.14.2 Zenotech Laboratories Biosimilars of Rituximab Product Overview
9.14.3 Zenotech Laboratories Biosimilars of Rituximab Product Market Performance
9.14.4 Zenotech Laboratories Business Overview
9.14.5 Zenotech Laboratories Recent Developments
10 Biosimilars of Rituximab Market Forecast by Region
10.1 Global Biosimilars of Rituximab Market Size Forecast
10.2 Global Biosimilars of Rituximab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biosimilars of Rituximab Market Size Forecast by Country
10.2.3 Asia Pacific Biosimilars of Rituximab Market Size Forecast by Region
10.2.4 South America Biosimilars of Rituximab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biosimilars of Rituximab by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biosimilars of Rituximab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biosimilars of Rituximab by Type (2025-2030)
11.1.2 Global Biosimilars of Rituximab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biosimilars of Rituximab by Type (2025-2030)
11.2 Global Biosimilars of Rituximab Market Forecast by Application (2025-2030)
11.2.1 Global Biosimilars of Rituximab Sales (Kilotons) Forecast by Application
11.2.2 Global Biosimilars of Rituximab Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biosimilars of Rituximab Market Size Comparison by Region (M USD)
Table 5. Global Biosimilars of Rituximab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Biosimilars of Rituximab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biosimilars of Rituximab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biosimilars of Rituximab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars of Rituximab as of 2022)
Table 10. Global Market Biosimilars of Rituximab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biosimilars of Rituximab Sales Sites and Area Served
Table 12. Manufacturers Biosimilars of Rituximab Product Type
Table 13. Global Biosimilars of Rituximab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biosimilars of Rituximab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biosimilars of Rituximab Market Challenges
Table 22. Global Biosimilars of Rituximab Sales by Type (Kilotons)
Table 23. Global Biosimilars of Rituximab Market Size by Type (M USD)
Table 24. Global Biosimilars of Rituximab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Biosimilars of Rituximab Sales Market Share by Type (2019-2024)
Table 26. Global Biosimilars of Rituximab Market Size (M USD) by Type (2019-2024)
Table 27. Global Biosimilars of Rituximab Market Size Share by Type (2019-2024)
Table 28. Global Biosimilars of Rituximab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Biosimilars of Rituximab Sales (Kilotons) by Application
Table 30. Global Biosimilars of Rituximab Market Size by Application
Table 31. Global Biosimilars of Rituximab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Biosimilars of Rituximab Sales Market Share by Application (2019-2024)
Table 33. Global Biosimilars of Rituximab Sales by Application (2019-2024) & (M USD)
Table 34. Global Biosimilars of Rituximab Market Share by Application (2019-2024)
Table 35. Global Biosimilars of Rituximab Sales Growth Rate by Application (2019-2024)
Table 36. Global Biosimilars of Rituximab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Biosimilars of Rituximab Sales Market Share by Region (2019-2024)
Table 38. North America Biosimilars of Rituximab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Biosimilars of Rituximab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Biosimilars of Rituximab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Biosimilars of Rituximab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Biosimilars of Rituximab Sales by Region (2019-2024) & (Kilotons)
Table 43. Amgen Biosimilars of Rituximab Basic Information
Table 44. Amgen Biosimilars of Rituximab Product Overview
Table 45. Amgen Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Amgen Business Overview
Table 47. Amgen Biosimilars of Rituximab SWOT Analysis
Table 48. Amgen Recent Developments
Table 49. AryoGen Pharmed Biosimilars of Rituximab Basic Information
Table 50. AryoGen Pharmed Biosimilars of Rituximab Product Overview
Table 51. AryoGen Pharmed Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AryoGen Pharmed Business Overview
Table 53. AryoGen Pharmed Biosimilars of Rituximab SWOT Analysis
Table 54. AryoGen Pharmed Recent Developments
Table 55. Biocad Biosimilars of Rituximab Basic Information
Table 56. Biocad Biosimilars of Rituximab Product Overview
Table 57. Biocad Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Biocad Biosimilars of Rituximab SWOT Analysis
Table 59. Biocad Business Overview
Table 60. Biocad Recent Developments
Table 61. Cadila Pharmaceuticals Biosimilars of Rituximab Basic Information
Table 62. Cadila Pharmaceuticals Biosimilars of Rituximab Product Overview
Table 63. Cadila Pharmaceuticals Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Cadila Pharmaceuticals Business Overview
Table 65. Cadila Pharmaceuticals Recent Developments
Table 66. Celltrion Biosimilars of Rituximab Basic Information
Table 67. Celltrion Biosimilars of Rituximab Product Overview
Table 68. Celltrion Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Celltrion Business Overview
Table 70. Celltrion Recent Developments
Table 71. Dr Reddy?s Laboratories Biosimilars of Rituximab Basic Information
Table 72. Dr Reddy?s Laboratories Biosimilars of Rituximab Product Overview
Table 73. Dr Reddy?s Laboratories Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Dr Reddy?s Laboratories Business Overview
Table 75. Dr Reddy?s Laboratories Recent Developments
Table 76. Teva Biosimilars of Rituximab Basic Information
Table 77. Teva Biosimilars of Rituximab Product Overview
Table 78. Teva Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Teva Business Overview
Table 80. Teva Recent Developments
Table 81. Hetero Group Biosimilars of Rituximab Basic Information
Table 82. Hetero Group Biosimilars of Rituximab Product Overview
Table 83. Hetero Group Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Hetero Group Business Overview
Table 85. Hetero Group Recent Developments
Table 86. Innovent Biologics Biosimilars of Rituximab Basic Information
Table 87. Innovent Biologics Biosimilars of Rituximab Product Overview
Table 88. Innovent Biologics Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Innovent Biologics Business Overview
Table 90. Innovent Biologics Recent Developments
Table 91. Intas Biopharmaceuticals Biosimilars of Rituximab Basic Information
Table 92. Intas Biopharmaceuticals Biosimilars of Rituximab Product Overview
Table 93. Intas Biopharmaceuticals Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Intas Biopharmaceuticals Business Overview
Table 95. Intas Biopharmaceuticals Recent Developments
Table 96. Viatris Biosimilars of Rituximab Basic Information
Table 97. Viatris Biosimilars of Rituximab Product Overview
Table 98. Viatris Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Viatris Business Overview
Table 100. Viatris Recent Developments
Table 101. Probiomed Biosimilars of Rituximab Basic Information
Table 102. Probiomed Biosimilars of Rituximab Product Overview
Table 103. Probiomed Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Probiomed Business Overview
Table 105. Probiomed Recent Developments
Table 106. TRPharma Biosimilars of Rituximab Basic Information
Table 107. TRPharma Biosimilars of Rituximab Product Overview
Table 108. TRPharma Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. TRPharma Business Overview
Table 110. TRPharma Recent Developments
Table 111. Zenotech Laboratories Biosimilars of Rituximab Basic Information
Table 112. Zenotech Laboratories Biosimilars of Rituximab Product Overview
Table 113. Zenotech Laboratories Biosimilars of Rituximab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Zenotech Laboratories Business Overview
Table 115. Zenotech Laboratories Recent Developments
Table 116. Global Biosimilars of Rituximab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Biosimilars of Rituximab Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Biosimilars of Rituximab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Biosimilars of Rituximab Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Biosimilars of Rituximab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Biosimilars of Rituximab Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Biosimilars of Rituximab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Biosimilars of Rituximab Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Biosimilars of Rituximab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Biosimilars of Rituximab Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Biosimilars of Rituximab Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Biosimilars of Rituximab Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Biosimilars of Rituximab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Biosimilars of Rituximab Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Biosimilars of Rituximab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Biosimilars of Rituximab Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Biosimilars of Rituximab Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Biosimilars of Rituximab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biosimilars of Rituximab Market Size (M USD), 2019-2030
Figure 5. Global Biosimilars of Rituximab Market Size (M USD) (2019-2030)
Figure 6. Global Biosimilars of Rituximab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biosimilars of Rituximab Market Size by Country (M USD)
Figure 11. Biosimilars of Rituximab Sales Share by Manufacturers in 2023
Figure 12. Global Biosimilars of Rituximab Revenue Share by Manufacturers in 2023
Figure 13. Biosimilars of Rituximab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biosimilars of Rituximab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biosimilars of Rituximab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biosimilars of Rituximab Market Share by Type
Figure 18. Sales Market Share of Biosimilars of Rituximab by Type (2019-2024)
Figure 19. Sales Market Share of Biosimilars of Rituximab by Type in 2023
Figure 20. Market Size Share of Biosimilars of Rituximab by Type (2019-2024)
Figure 21. Market Size Market Share of Biosimilars of Rituximab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biosimilars of Rituximab Market Share by Application
Figure 24. Global Biosimilars of Rituximab Sales Market Share by Application (2019-2024)
Figure 25. Global Biosimilars of Rituximab Sales Market Share by Application in 2023
Figure 26. Global Biosimilars of Rituximab Market Share by Application (2019-2024)
Figure 27. Global Biosimilars of Rituximab Market Share by Application in 2023
Figure 28. Global Biosimilars of Rituximab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biosimilars of Rituximab Sales Market Share by Region (2019-2024)
Figure 30. North America Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Biosimilars of Rituximab Sales Market Share by Country in 2023
Figure 32. U.S. Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Biosimilars of Rituximab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Biosimilars of Rituximab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Biosimilars of Rituximab Sales Market Share by Country in 2023
Figure 37. Germany Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Biosimilars of Rituximab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Biosimilars of Rituximab Sales Market Share by Region in 2023
Figure 44. China Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Biosimilars of Rituximab Sales and Growth Rate (Kilotons)
Figure 50. South America Biosimilars of Rituximab Sales Market Share by Country in 2023
Figure 51. Brazil Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Biosimilars of Rituximab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Biosimilars of Rituximab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Biosimilars of Rituximab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Biosimilars of Rituximab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Biosimilars of Rituximab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biosimilars of Rituximab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biosimilars of Rituximab Market Share Forecast by Type (2025-2030)
Figure 65. Global Biosimilars of Rituximab Sales Forecast by Application (2025-2030)
Figure 66. Global Biosimilars of Rituximab Market Share Forecast by Application (2025-2030)
